The Queen's Ark was established with the original intention of being committed to accelerating scientific innovation through a brand-new operation model to benefit patients, which is the top priority of all our work. We possess strong commercial transformation capabilities and, together with our partners, address a series of medical challenges faced at different stages of product development and for various disease types.

Around the world, countless cancer patients are confronted with huge challenges every day, and a large number of treatment needs cannot be fully met. Some patients search hard just to find an effective medicine, while others, although having potential treatment options, cannot afford the high treatment costs. In the face of these challenges, Shanghai Queen's Ark Pharmaceuticals Co., Ltd was born on February 21, 2024.

At present, taking anti-cancer drugs as the entry point, whether it's small molecules, antibody drugs, antibody-drug conjugates (ADC), cell therapies, gene therapies or therapeutic cancer vaccines, they are all included in our product pipelines for license-in and license-out. Our strategy is that in the first 1 - 2 years after the company's establishment, it will be driven by business development (BD), and then we will start research and development, production and sales. The short-term goal is to be listed on the NASDAQ in the United States within five years. Five years later, the business scope will be expanded to drug types in the fields of autoimmune diseases, infections, rare diseases and so on. The long-term goal is to become an internationally renowned large pharmaceutical enterprise from China and provide accessible and affordable high-quality innovative drugs for patients all over the world.

In order to realize the aspiration of "pooling global resources to develop innovative drugs for the world", we are dedicated to cooperating with elites in the investment, academic and pharmaceutical fields around the world to bring innovative high-quality drugs to patients globally. We choose like-minded partners, adhere to the commitment of putting patients at the center, and are committed to transforming scientific achievements into blessings for humanity. We join hands with like-minded partners, focus on patients and strive for excellent science to ensure that we can jointly help patients in need around the world obtain treatment. At The Queen's Ark, we hope that no matter where patients are, they have the right to obtain affordable innovative drugs. In order to enable more patients to use life-saving innovative therapies more quickly, our clinical trials will be carried out globally, so as to develop high-quality drugs faster than ordinary clinical trials.

Through our research, development and commercialization, together with our partners, we will bring our therapies to new regions in the world, make full use of partnerships to fulfill our mission and enable more people to obtain crucial drugs. The Queen's Ark has always been patient-centered. Driven by this concept, we are committed to providing all the necessary support for patients and their caregivers in a meticulous manner.